Antimicrobial susceptibility pattern of Pseudomonas aeruginosa and antibiotic use in King Fahd Hospital of the University in Khobar, Saudi Arabia

Scientific Journal of King Faisal University Basic and Applied Sciences

Volumn 11, Issue 1, 2010, Pages 185-192

  Bukharie, Huda A ^a   Mowafi, Hany A ^b  

^a Infectious Disease Unit   (Saudi Arabia)

^b IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79251468730     PISSN: 16580311     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. National Nosocomial Infection Surveillance System. 1999. National Nosocomial Infection Surveillance (NNIS) System Report, data Summary from January 1990-May 1999, issued June 1999. Am J Infect Control 2001; 27:520-532.
2. Quinn J.P. Clinical problems posed by multiresistant nonfermenting Gram-negative pathogens. Clin Infect Dis 1998 27: S117-S124.
3. Giamarellou H. Prescribing guidelines for severe Pseudomonas infections. J Antimicrob Chemother 2002 49: 229-233.
4. Ballow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis 1992;15:37S-42S.
5. Rello J, Rue M, Jubert P, et al. Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 1997;25:1862-70.
6. Carmeli Y, Troillet N, Eliopoulos GM, et al. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risk associated with different anti-pseudomonal agents. Antimicrob Agents Chemother 1999;43:1379-82.
7. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31:S131-8.
8. Jones RN, Kirby JT, et al. Geographic variation of broad spectrum B-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000). Diag Microbial Infect Dis 2002; 43:239-243.
9. Gales AC, Jones RN, Turnidge J, et al. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32:S146-55.
10. Obritsch MD, Fish DN, et al. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993-2002. Antimicrob Agents Chemother 2004; 48:4606-4610.
11. Gentry CH, Flournoy D J, Reinert R. Analysis of antimicrobial resistance among gram-negative bacilli and antimicrobial use in intensive care unit patients for 5 years in a veterans affairs medical center. Am J Infect Control 2002; 30: 411-6.
12. Gerding DN, Larson TA, Hughes RA, et al: Aminoglycoside resistance and aminoglycoside usage: Ten years of experience in one hospital. Antimicrob Agents Chemother 1991; 35: 1284-1290.
13. Pfaller M, Jones R, et al. Antimicrobial resistance trends in medical centers using carbapenems: Report of 1999 and 2000 result from the MYSTIC program. Diag Microbial Infect Dis 2001; 41:177-182.
14. Babay HA. Antimicrobial resistance among isolates of Pseudomonas aeruginosa from patients in a teaching hospital , Riyadh, Saudi Arabia. Jpn J Infect Dis2007;60:123-125.
15. Al-Tawfiq JA. Occurrence and antimicrobial resistant pattern of inpatients and outpatients isolates of Pseudomonas aeruginosa in a Saudi Arabian hospital. Int J Infect Dis 2007;11:109-114.